Home > Worth supplementing buprenorphine with therapy?

Drug and Alcohol Findings. (2016) Worth supplementing buprenorphine with therapy? Drug and Alcohol Findings Research Analysis, (13 December 2016),

PDF (A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine.)

External website: http://findings.org.uk/PHP/dl.php?file=Fiellin_DA_...

Provide psychosocial therapy as well as buprenorphine, or extend treatment to more opioid-dependent patients by not requiring therapy? Across relatively uncomplicated patients treated at a primary care clinic, this US study found no benefit from cognitive-behavioural therapy, but other patients may need this kind of support to make the most of buprenorphine or methadone treatment.

Key points From summary and commentary
• US primary care practices which prescribe buprenorphine to opioid-dependent patients generally offer only limited counselling, raising the issue of whether further psychosocial support would improve outcomes.
• At a US practice, this randomised trial supplemented medical care with cognitive-behavioural therapy.
• There was no statistically significant indication that adding these sessions further reduced opioid or cocaine use or improved the treatment-completion rate or other outcomes.
• Some patients in opiate substitute prescribing programmes have however benefited from extra counselling or therapy. Patients with psychiatric problems may particularly benefit.

Repository Staff Only: item control page